Evidence map›Paper›PMID 27886074›Full record

ArticleViruses2016

Eleventh International Foamy Virus Conference-Meeting Report.

Florence Buseyne, Antoine Gessain, Marcelo A Soares, André F Santos, Magdalena Materniak-Kornas, Pascale Lesage, Alessia Zamborlini, Martin Löchelt, Wentao Qiao, Dirk Lindemann and 4 more

Open access · goldAbstract readConference Proceedings
PubMed Full text at PMC Publisher
In one paragraph

Article in Viruses, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 9 institutions in 7 countries.

Florence BuseyneUnité d'Épidémiologie et Physiopathologie des Virus Oncogènes, Institut Pasteur, 75015 Paris, France. florence.buseyne@pasteur.fr.
Antoine GessainUnité d'Épidémiologie et Physiopathologie des Virus Oncogènes, Institut Pasteur, 75015 Paris, France. antoine.gessain@pasteur.fr.
Marcelo A SoaresDepartment of Genetics, Universidade Federal do Rio de Janeiro, 21949-570 Rio de Janeiro, Brazil. masoares@biologia.ufrj.br.
André F SantosDepartment of Genetics, Universidade Federal do Rio de Janeiro, 21949-570 Rio de Janeiro, Brazil. andre.santos@ufrj.br.
Magdalena Materniak-KornasDepartment of Biochemistry, National Veterinary Research Institute, 24-100 Pulawy, Poland. magdalena.materniak@piwet.pulawy.pl.
Pascale LesageInstitut Universitaire d'Hématologie, Hôpital Saint-Louis, Université Paris Diderot, Sorbonne Paris Cité, INSERM U944, CNRS UMR 7212, 75010 Paris, France. pascale.lesage@inserm.fr.
Alessia ZamborliniInstitut Universitaire d'Hématologie, Hôpital Saint-Louis, Université Paris Diderot, Sorbonne Paris Cité, INSERM U944, CNRS UMR 7212, 75010 Paris, France. alessia.zamborlini@univ-paris-diderot.fr.
Martin LöcheltDepartment of Molecular Diagnostics of Oncogenic Infections, Research Program Infection, Inflammation and Cancer, 69120 Heidelberg, Germany. m.loechelt@dkfz.de.
Wentao QiaoKey Laboratory of Molecular Microbiology and Technology, Ministry of Education, College of Life Sciences, Nankai University, Tianjin 300071, China. wentaoqiao@nankai.edu.cn.
Dirk LindemannInstitute of Virology, Medical Faculty "Carl Gustav Carus", Technische Universität Dresden, 01307 Dresden, Germany. dirk.lindemann@tu-dresden.de.
Birgitta M WöhrlUniversity of Bayreuth, Department of Biopolymers, 95447 Bayreuth, Germany. birgitta.woehrl@uni-bayreuth.de.
Jonathan P StoyeFrancis Crick Institute, London NW1 1AT, UK. jonathan.stoye@crick.ac.uk.
Ian A TaylorFrancis Crick Institute, London NW1 1AT, UK. ian.taylor@crick.ac.uk.
Arifa S KhanLaboratory of Retroviruses, Division of Viral Products, OVRR, CBER, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA. arifa.khan@fda.hhs.gov.
Centre National de la Recherche Scientifique · FRThe Francis Crick Institute · GBUniversidade Federal do Rio de Janeiro · BRConservatoire National des Arts et Métiers · FRNankai University · CNNational Veterinary Research Institute · PLUnited States Food and Drug Administration · USUniversity Hospital Carl Gustav Carus · DEUniversity of Bayreuth · DE

Funding

Medical Research Council MC_U117512710
6 · The paper itself

Abstract

The Eleventh International Foamy Virus Conference took place on 9-10 June 2016 at the Institut Pasteur, Paris, France. The meeting reviewed progress on foamy virus (FV) research, as well as related current topics in retrovirology. FVs are complex retroviruses that are widespread in several animal species. Several research topics on these viruses are relevant to human health: cross-species transmission and viral emergence, vectors for gene therapy, development of antiretroviral drugs, retroviral evolution and its influence on the human genome. In this article, we review the conference presentations on these viruses and highlight the major questions to be answered.

Indexed as

AnimalsAntiviral AgentsDisease Transmission, InfectiousGenetic VectorsHumansParisRetroviridae InfectionsSpumavirusAntiviral Agentscross-species virus transmissionfoamy virusFV vectorsimmune responseslatent infectionrestriction factorsvirus replicationzoonosis

Identifiers

PMID27886074
PMCPMC5127032
OpenAlexW2553387612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.